🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCagriSema (amylin + semaglutide) — my results so far Page 4

CagriSema (amylin + semaglutide) — my results so far

Dr.NutriCornell Sun, Jan 4, 2026 at 9:59 AM 31 replies 1,170 viewsPage 4 of 7
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Jan 4, 2026 at 3:39 PM#16

Just wanted to say — for anyone reading this CagriSema (amylin + thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

Last edited: Jan 4, 2026 at 4:39 PM
1 11rachel_ABQ
Reply Quote Save Share Report
fiona_VT
Member
178
890
Dec 2024
Vermont
Jan 4, 2026 at 3:56 PM#17

Dr.NutriCornell's experience with CagriSema (amylin + resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I started 3 months later. But the overall trajectory has been remarkably similar. Down 34 lbs in 9 months.

One thing I would add that Dr.NutriCornell did not mention: the mental health improvements were just as significant.

Last edited: Jan 4, 2026 at 4:56 PM
4 0hans_munich, jason_sac26, chris_chi24 and 1 other
Reply Quote Save Share Report
NeuroNate
Senior Member
2,890
16,789
Dec 2023
Chicago, IL
Jan 4, 2026 at 4:13 PM#18

Saving this for reference. Top-tier content.

Last edited: Jan 4, 2026 at 10:13 PM
29 21sarah_TO, wendy_avl, jason_paloalto and 26 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Jan 4, 2026 at 4:30 PM#19

As a pharmacist, I want to add some clinical context to this discussion on CagriSema (amylin + semaglutide) my.

Building on what Dr.NutriCornell said — the evidence base here is robust. The key publications to reference are from the SURMOUNT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
12 3BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 9 others
Reply Quote Save Share Report
Dr.KarenChen
VIP Member
4,210
24,567
Nov 2023
San Francisco, CA
Jan 4, 2026 at 4:47 PM#20

Subscribing to this thread. CagriSema (amylin + is exactly what I've been researching. 🙏

11 11sarah_nash92, FitDadDave, RunnerRach and 8 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register